Abstract:AbstractBackgroundNeuroinflammation plays an important role in cerebral ischemia/reperfusion (I/R) injury. The P2X7 receptor (P2X7R) has been reported to be involved in the inflammatory response of many central nervous system diseases. However, the role of P2X7Rs in transient global cerebral I/R injury remains unclear. The purpose of this study is to determine the effects of inhibiting the P2X7R in a rat model of transient global cerebral I/R injury, and then to explore the association between the P2X7R and neuroinflammation after transient global cerebral I/R injury.MethodsImmediately after infusion with the P2X7R antagonists Brilliant blue G (BBG), adenosine 5′-triphosphate-2′,3′-dialdehyde (OxATP) or A-438079, 20 minutes of transient global cerebral I/R was induced using the four-vessel occlusion (4-VO) method in rats. Survival rate was calculated, neuronal death in the hippocampal CA1 region was observed using H & E staining, and DNA cleavage was observed by deoxynucleotidyl transferase-mediated UTP nick end labeling TUNEL). In addition, behavioral deficits were measured using the Morris water maze, and RT-PCR and immunohistochemical staining were performed to measure the expression of IL-1β, TNF-α and IL-6, and to identify activated microglia and astrocytes.ResultsThe P2X7R antagonists protected against transient global cerebral I/R injury in a dosage-dependent manner. A high dosage of BBG (10 μg) and A-0438079 (3 μg), and a low dosage of OxATP (1 μg) significantly increased survival rates, reduced I/R-induced learning memory deficit, and reduced I/R-induced neuronal death, DNA cleavage, and glial activation and inflammatory cytokine overexpression in the hippocampus.ConclusionsOur study indicates that inhibiting P2X7Rs protects against transient global cerebral I/R injury by reducing the I/R-induced inflammatory response, which suggests inhibition of P2X7Rs may be a promising therapeutic strategy for clinical treatment of transient global cerebral I/R injury.

P2 Receptors for Extracellular Nucleotides in the Central Nervous System: Role of P2X7 and P2Y2 Receptor Interactions in Neuroinflammation

P2X and P2Y Receptors—Role in the Pathophysiology of the Nervous System

P2X Receptor-Dependent Modulation of Mast Cell and Glial Cell Activities in Neuroinflammation

Implication of Neuronal Versus Microglial P2X4 Receptors in Central Nervous System Disorders

Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases

Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders

Inhibition of P2X7 Receptor Ameliorates Transient Global Cerebral Ischemia/reperfusion Injury Via Modulating Inflammatory Responses in the Rat Hippocampus

Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists

A current review on P2X7 receptor antagonist patents in the treatment of neuroinflammatory disorders: a patent review on antagonists

P2Y6 receptor and immunoinflammation

P2Y Receptors in Immune Response and Inflammation

P2x(7) Receptors: Properties And Relevance To Cns Function

The P2Y12 receptor regulates microglial activation by extracellular nucleotides

The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases

Modulation of Microglial Function by ATP-Gated P2X7 Receptors: Studies in Rat, Mice and Human

Strategies for targeting the P2Y12 receptor in the central nervous system

Cross Talk on P2X4 Purinergic Receptors and Neuropathic Pain

The Role of P2X7R in Neuroinflammation and Implications in Alzheimer's Disease.

Role of P2X4 receptor,a subtype of ionotropic purinoceptors, in central nervous system and its potential role as a drug target for treating neurological disorders

P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases

Astrocytic and Oligodendrocytic P2X7 Receptors Determine Neuronal Functions in the CNS